Cephalosporin antibiotics are important chemotherapeutic agents because of their broad antibacterial spectrum, which includes many species of gram-negative organisms that have become the major species causing hospital infections in the past 2 decades. Changes in the chemical structure of the cephalosporins have resulted in an increased antibacterial spectrum, more useful pharmacokinetic properties, and, in some cases, a high level of resistance to fi-lactamase hydrolysis. The presence of fi-lactamases in gram-negative organisms has been associated with resistance to cephalosporins, although these enzymes are not the only factor contributing to the resistance of gram-negative bacilli to f3-lactam compounds (3, 9, 10, 15) . There is great interest in antibiotics that are resistant to fl-lactamase hydrolysis and in compounds that are inhibitors of 8B-lactamases (2, 5, 11 (11) . Recently, naturally occurring inhibitors of ,B-lactamases produced by streptomyces have been discovered (1, 14) . Cefoxitin and cefuroxime, two new fi-lactam compounds, have been reported to be resistant to B8-lactamases of gram-negative bacilli (3, 12) .
HR 756 (Fig. 1 ) has been shown to be active against many bacteria resistant to the older cephalosporins (6; H. C. Neu, N. Aswapokee, and K. P. Fu, manuscript in preparation). We wished to assess the fl-lactamase resistance of this compound and to compare its resistance to f)-lactamase hydrolysis with the resistance of cefoxitin and cefuroxime.
MATERIALS AND METHODS
Organisms. Shigella sonnei 10-101, Pseudomonas aeruginosa 3901, Proteus morganii 771, Proteus mirabilis 3378, Citrobacter freundii 2732, Klebsiella pneumoniae 3973, and P. aeruginosa 1822 were clinical isolates that had been selected for study on the basis of their resistance to one or more ,B-lactam antibiotics and the presence of ,B-lactamases (4 
RESULTS
The in vitro susceptibility of the organisms used is given in Table 1 (Fig. 2) . HR 756 and cefuroxime were of equal effectiveness as inhibitors of the two 13-lactamases: both inhibited 80% of activity at a concentration of 0.1 ,uM, whereas cefoxitin was approximately 50-fold less effective than the other two agents, inhibiting 80% of activity at the concentration of 5 ,zM. Cefoxitin and cefuroxime were competitive inhibitors of both the type I ,B-lactamases ( Fig. 3 and 4) . HR 756 was a noncompetitive inhibitor of the /3-lactamase of ANTIMICROB. AGENTS CHEMOTHER.
Citrobacter (Fig. 3) and was a competitive inhibitor of the ,B-lactamases of P. morganii (Fig. 4) . Table 2 , footnote c. 
